Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: towards tumor-directed oligoclonal T cell therapy.

Jamnani FR, Rahbarizadeh F, Shokrgozar MA, Mahboudi F, Ahmadvand D, Sharifzadeh Z, Parhamifar L, Moghimi SM.

Biochim Biophys Acta. 2014 Jan;1840(1):378-86. doi: 10.1016/j.bbagen.2013.09.029. Epub 2013 Sep 27.

PMID:
24076235
2.

Quantum dots incorporated magnetic nanoparticles for imaging colon carcinoma cells.

Ahmed S, Dong J, Yui M, Kato T, Lee J, Park EY.

J Nanobiotechnology. 2013 Aug 17;11:28. doi: 10.1186/1477-3155-11-28.

3.

Comparing two TAG-72 binding peptides previously identified by phage display as potential imaging agents.

Chen L, Wang Y, Cheng D, Dou S, Liu X, Liu G, Hnatowich DJ, Rusckowski M.

Nucl Med Commun. 2011 Oct;32(10):920-4. doi: 10.1097/MNM.0b013e328348fc64.

4.

Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages.

Allavena P, Chieppa M, Bianchi G, Solinas G, Fabbri M, Laskarin G, Mantovani A.

Clin Dev Immunol. 2010;2010:547179. doi: 10.1155/2010/547179. Epub 2011 Feb 9.

5.

Identification of a high affinity TAG-72 binding peptide by phage display selection.

Xiao N, Cheng D, Wang Y, Chen L, Liu X, Dou S, Liu G, Liang M, Hnatowich DJ, Rusckowski M.

Cancer Biol Ther. 2011 Jan 1;11(1):22-31. Epub 2011 Jan 1.

6.

Regulation of NK-cell function by mucins via antigen-presenting cells.

Laskarin G, Redzovic A, Medancic SS, Rukavina D.

Med Hypotheses. 2010 Dec;75(6):541-3. doi: 10.1016/j.mehy.2010.07.023. Epub 2010 Aug 10.

PMID:
20702048
7.

Tumor targeting of humanized fragment antibody secreted from transgenic rice cell suspension culture.

Hong SY, Lee TS, Kim J, Jung JH, Choi CW, Kim TG, Kwon TH, Jang YS, Yang MS.

Plant Mol Biol. 2008 Nov;68(4-5):413-22. doi: 10.1007/s11103-008-9379-4. Epub 2008 Aug 1.

PMID:
18670890
8.
9.

Evidence of specificity of radiolabeled phage display peptides for the TAG-72 antigen.

Rusckowski M, Gupta S, Liu G, Dou S, Hnatowich DJ.

Cancer Biother Radiopharm. 2007 Aug;22(4):564-72.

PMID:
17803452
10.

Characterization of a CC49-based single-chain fragment-beta-lactamase fusion protein for antibody-directed enzyme prodrug therapy (ADEPT).

Alderson RF, Toki BE, Roberge M, Geng W, Basler J, Chin R, Liu A, Ueda R, Hodges D, Escandon E, Chen T, Kanavarioti T, Babé L, Senter PD, Fox JA, Schellenberger V.

Bioconjug Chem. 2006 Mar-Apr;17(2):410-8.

PMID:
16536473
11.

Construction, affinity maturation, and biological characterization of an anti-tumor-associated glycoprotein-72 humanized antibody.

Yoon SO, Lee TS, Kim SJ, Jang MH, Kang YJ, Park JH, Kim KS, Lee HS, Ryu CJ, Gonzales NR, Kashmiri SV, Lim SM, Choi CW, Hong HJ.

J Biol Chem. 2006 Mar 17;281(11):6985-92. Epub 2006 Jan 9.

12.

Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.

Rogers BE, Roberson PL, Shen S, Khazaeli MB, Carpenter M, Yokoyama S, Brechbiel MW, LoBuglio AF, Buchsbaum DJ.

Cancer Biother Radiopharm. 2005 Oct;20(5):502-13. Erratum in: Cancer Biother Radiopharm. 2005 Dec;20(6):671.

13.

Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region.

Natsume A, Wakitani M, Yamane-Ohnuki N, Shoji-Hosaka E, Niwa R, Uchida K, Satoh M, Shitara K.

J Immunol Methods. 2005 Nov 30;306(1-2):93-103. Epub 2005 Oct 3.

PMID:
16236307
14.

Novel antibody hinge regions for efficient production of CH2 domain-deleted antibodies.

Glaser SM, Hughes IE, Hopp JR, Hathaway K, Perret D, Reff ME.

J Biol Chem. 2005 Dec 16;280(50):41494-503. Epub 2005 Oct 12.

15.

Engineering and characterization of a divalent single-chain Fv angiotensin II fusion construct of the monoclonal antibody CC49.

Wittel UA, Jain M, Goel A, Baranowska-Kortylewicz J, Kurizaki T, Chauhan SC, Agrawal DK, Colcher D, Batra SK.

Biochem Biophys Res Commun. 2005 Apr 1;329(1):168-76.

PMID:
15721289
16.

Design and construction of a phosphorylatable chimeric monoclonal antibody with a highly stable phosphate.

Wu W, Kerrigan JE, Yadav P, Schwartz B, Izotova L, Lavoie TB, Pestka S.

Oncol Res. 2004;14(11-12):541-58.

PMID:
15666996
17.

Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro.

Kelly FJ, Miller CR, Buchsbaum DJ, Gomez-Navarro J, Barnes MN, Alvarez RD, Curiel DT.

Clin Cancer Res. 2000 Nov;6(11):4323-33.

18.

Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.

Pavlinkova G, Booth BJ, Batra SK, Colcher D.

Clin Cancer Res. 1999 Sep;5(9):2613-9.

19.
20.

Construction of phosphorylatable chimeric monoclonal antibody CC49 with a casein kinase I recognition site.

Lin L, Gillies SD, Schlom J, Pestka S.

Protein Expr Purif. 1999 Feb;15(1):83-91.

PMID:
10024474

Supplemental Content

Loading ...
Support Center